Universidad Complutense de Madrid
E-Prints Complutense

Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost

Impacto

Downloads

Downloads per month over past year

Martínez de la Casa, Jose Maria and Pérez Bartolomé, Francisco and Urcelay, Elena and Santiago, José Luis and Moreno Montañes, Javier and Arriola Villalobos, Pedro and Benítez del Castillo, José Manuel and García Feijoo, Julián (2017) Tear cytokine profile of glaucoma patients treated with preservative-free or preserved latanoprost. Ocular surface . ISSN 1542-0124 (In Press)

[img]
Preview
PDF (Corrected proof. En prensa)
Creative Commons Attribution Non-commercial No Derivatives.

359kB

Official URL: https://doi.org/10.1016/j.jtos.2017.03.004




Abstract

Purpose: To determine variations in cytokine levels of glaucoma patients treated either with preservative-free latanoprost or preserved latanoprost, relative to healthy individuals. Methods: Tear samples were collected from 39 healthy subjects, 20 glaucoma patients treated with preserved latanoprost, and 20 patients treated with preservative-free latanoprost. A set of 27 inflammatory cytokines was analyzed in each group, including interleukin (IL)-1β, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL9, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, eotaxin, fibroblast growth factor (FGF) basic, granulocyte colony stimulating factor (G-CSF), granulocyte monocyte colony stimulating factor (GM-CSF), interferon (IFN)-γ, interferon gamma-induced protein (IP)-10, monocyte chemo attractant protein (MCP)-1MCAF, macrophage inflammatory protein (MIP)-1α, MIP-1β, platelet-derived growth factor (PDGF)-BB, regulated on activation, normal T cell expressed and secreted (RANTES), tumor necrosis factor (TNF)-α and vascular endothelial growth factor (VEGF). Cytokine concentrations were obtained by the Bio-Plex Human Cytokine Immunoassay. Non-invasive tear breakup time (NI-TBUT), tear meniscus height, corneal fluorescein staining, conjunctival hyperemia and ocular surface disease index (OSDI) were assessed in patients treated with preservative-free and preserved latanoprost. Results: The levels of IL-2, IL-5, IL-10, IL-12 (p70), IL-13, IL-15, IL-17, FGF basic, PDGF-BB, and TNF-α were significantly higher in patients receiving preserved latanoprost, compared to normal controls (p < 0.05). The expression of all the cytokines studied remained statistically invariable in patients receiving preservative-free latanoprost, compared to healthy subjects (p > 0.05). Ocular surface parameters were not significantly different in both glaucoma groups, and no correlation between these clinical parameters and cytokine levels was observed. Conclusions: Treatment with preserved latanoprost has a direct impact on tear cytokine levels, whereas this effect is not observed upon preservative-free latanoprost instillation.


Item Type:Article
Additional Information:

Received 14 December 2016, Revised 21 March 2017, Accepted 21 March 2017, Available online 22 March 2017.

Uncontrolled Keywords:Cytokine; Glaucoma; Inflammation; Latanoprost; Ocular surface disease; Preservatives
Subjects:Medical sciences > Medicine > Ophtalmology
Medical sciences > Pharmacy > Drugs
ID Code:42709
Deposited On:02 Jun 2017 11:45
Last Modified:22 Mar 2018 00:01

Origin of downloads

Repository Staff Only: item control page